Asia Pacific Cell & Gene Therapy Contract Research Organizations Market Size & Outlook

The cell & gene therapy contract research organizations market in Asia Pacific is expected to reach a projected revenue of US$ 2,432.3 million by 2033. A compound annual growth rate of 10.9% is expected of Asia Pacific cell & gene therapy contract research organizations market from 2025 to 2033.
Revenue, 2024 (US$M)
$962.5
Forecast, 2033 (US$M)
$2,432.3
CAGR, 2025 - 2033
10.9%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific cell & gene therapy contract research organizations market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Asia Pacific cell & gene therapy contract research organizations market highlights

  • The Asia Pacific cell & gene therapy contract research organizations market generated a revenue of USD 962.5 million in 2024.
  • The market is expected to grow at a CAGR of 10.9% from 2025 to 2033.
  • In terms of segment, clinical was the largest revenue generating type in 2024.
  • Preclinical is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2033.


Asia Pacific data book summary

Market revenue in 2024USD 962.5 million
Market revenue in 2033USD 2,432.3 million
Growth rate10.9% (CAGR from 2025 to 2033)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Preclinical, Clinical


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 19.9% of the global cell & gene therapy contract research organizations market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,432.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell & Gene Therapy Contract Research Organizations Market Companies

Name Profile # Employees HQ Website
Vince & Associates Clinical Research | An Altasciences Company View profile 101-250 Overland Park, Kansas, United States, North America http://vinceandassociates.com
Allucent View profile 11-50 Rexburg, Idaho, United States, North America https://allucent.io/
QPS Holdings View profile 1001-5000 Newark, Delaware, United States, North America https://www.qps.com
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Precision Diagnostics View profile 251-500 San Diego, California, United States, North America https://www.precisiondxlab.com/
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Asia Pacific cell & gene therapy contract research organizations market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy contract research organizations market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 83.08% in 2024. Horizon Databook has segmented the Asia Pacific cell & gene therapy contract research organizations market based on drug discovery, preclinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Asia Pacific cell & gene therapy contract research organizations market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific cell & gene therapy contract research organizations market databook

  • Our clientele includes a mix of cell & gene therapy contract research organizations market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cell & gene therapy contract research organizations market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cell & gene therapy contract research organizations market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific cell & gene therapy contract research organizations market size, by country, 2021-2033 (US$M)

Asia Pacific Cell & Gene Therapy Contract Research Organizations Market Outlook Share, 2024 & 2033 (US$M)

Asia Pacific cell & gene therapy contract research organizations market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online